As the fourth collaboration to be announced by 4D over the last year, we are realizing our vision of creating a robust product pipeline with our partners. Together we can potentially develop transformative new gene therapies. “We believe that great synergies can be achieved by combining our AAV gene therapy platform discovery with Roche’s expertise in novel biologics. “We are thrilled to enter into this collaboration with Roche, a global leader in research-focused healthcare,” said Dr. 4DMT will deploy its proprietary AAV vector discovery platform, Directed Vector Evolution, to identify and optimize novel gene delivery vectors for use in gene therapy products.
4D MOLECULAR THERAPEUTICS PHONE LICENSE
We harvest our data from various publically available data sources such as edgar database (SEC), form 5500 dataset (IRS), form 990 datasets (tax-exempt organizations) etc.4D Molecular Therapeutics (4DMT), a leader in next-generation gene therapy vector discovery and product development, today announced a collaboration and license agreement with Roche to discover and develop optimized next-generation AAV vectors for indications with high unmet medical need. 4D Molecular Therapeutics has disclosed updated preliminary safety and efficacy information from two 4D-310 INGLAXA Phase 1/2 clinical studies focusing on Fabry disease cardiomyopathy. We have a database of over 7.3M entities which can be searched to find the ein number of business entities. 4D Molecular Therapeutics (Nasdaq: FDMT), a clinical-stage biotherapeutics company harnessing the power of directed evolution for targeted genetic medicines. The Company designs, develops, and commercializes transformative gene therapeutic.
4D MOLECULAR THERAPEUTICS PHONE FREE
What is ?: Our website is a free resource to find the ein number for various business entities. 4d Molecular Therapeutics, LLC operates as a biotechnology company. Since all corporations - including ones with no income - must file at least a federal income tax return, a corporation operating or incorporated in the United States generally must obtain an EIN anyway either before or after being issued its charter. Also, financial institutions such as banks, credit unions, and brokerage houses will not open an account for a corporation without an EIN. 4D Molecular Therapeutics overview 4D Molecular Therapeutics is a gene therapy company that discovers and develops targeted and proprietary AAV gene therapy vectors and therapeutic products. To be considered a Partnership, LLC, Corporation, S Corporation, Non-profit, etc. Other commonly used terms for EIN are Taxpayer Id, IRS Number, Tax Id, Taxpayer Identification Number (TIN) etc.Ī business needs an EIN in order to pay employees and to file business tax returns. Central Index Key (CIK) is used to identify corporations who have filed disclosures and other filings with the SEC.Įmployer Identification Number (EIN): The Employer Identification Number (EIN), also known as the Federal Employer Identification Number (FEIN) or the Federal Tax Identification Number (FTIN), is a unique nine-digit number assigned by the Internal Revenue Service (IRS) (format: XX-XXXXXXXXX) to business entities operating in the United States for the purposes of identification and employment tax reporting. The CIK for 4d Molecular Therapeutics Inc is 1650648.
The Central Index Key (CIK) for 4d Molecular Therapeutics Inc is 1650648.īiological Products, (no Disgnostic Substances) 4d Molecular Therapeutics Inc is incorporated in Delaware and the fiscal year end is in 31 December. It is one of the corporates which submit 10-K filings with the SEC.
EIN for organizations is sometimes also referred to as taxpayer identification number or TIN or simply IRS Number. (Nasdaq: FDMT), a clinical-stage biotherapeutics company harnessing the power of directed evolution for.
The employer identification number (EIN) for 4d Molecular Therapeutics Inc is 473506994. 03, 2022 (GLOBE NEWSWIRE) - 4D Molecular Therapeutics, Inc. 4d Molecular Therapeutics Inc is a corporation in Emeryville, California.
0 kommentar(er)
